Bicycle ergometer excerciseStandard care with electrical cardioversion
Bicycle ergometer excercise: Patients will undergo a symptom-limited ergometer cycling test under medical supervision. If the atrial fibrillation is not converted to sinus rhythm during the exercise test, the patients will be electrically converted.
Standard care with electrical cardioversion: Standard care with planned electrical cardioversion without exercise intervention.
Study summary
This study aims to to evaluate the feasibility of conducting a larger randomized controlled trial (RCT) to assess whether an exercise stress test on an ergometer bicycle could induce sinus rhythm in patients with persistent AF scheduled for electrical cardioversion and if this intervention (regardless of rhythm conversion) could improve health-related quality of life in these patients.
Eligibility
Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
* Adults (18-75 years) with persistent AF
* planned for EC
* with at least 3 weeks of therapeutic oral anticoagulation before intervention
Exclusion Criteria:
* Unable to perform a symptom limited cycle exercise test
* Ischemic heart disease
* Heart failure
* Severe valvular disease
* Unable to speak and write Swedish language
* Unable to provide written, informed consent
Primary outcome measure(s)
Feasibility of the pilot study - Recruitment rate — Day 1 Number of patients asked to participate in the study
Feasibility of the pilot study - Consent rate — Day 1 Number of patients giving written consent to participate in the study
Feasibility of the pilot study - Participant fidelity — From enrollment to the end of assessments, an average of 2 months Ability of participants to comply with the intervention protocol.
Feasibility of the pilot study - Study retention — Through study completion, an average of 6 months Participants dropout rates.
Feasibility of the pilot study - Adverse events — Through study completion, an average of 6 months Side effects and adverse events during the study
Trial sites (1)
Facility
City
Region
Status
Centre for Clinical Research, Uppsala University, Västmanland County Hospital
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.